CNCR Summary


The Loncar Cancer Immunotherapy ETF

ETF Information as of 08/22/2017

ETF Summary

ETF Info
Primary Exchange NASDAQ
Ticker CNCR
Index Symbol LCINDX
Index Provider Loncar Investments, LLC
Index Calculator Indxx, LLC
CUSIP 26922A826
Net Assets $35,829,899.28
Shares Outstanding 1,600,000
Number of Holdings 31
Weighting Equal-Weighted
Rebalanced Semi-Annually
Reconstituted Semi-Annually
Fund Inception Date 10/13/15
Management Fee 0.79%
Gross Expense Ratio 0.79%
Net Asset Value $22.39
Daily Change
Market Price
Closing Price $22.41
Daily Change $0.58
Premium Discount
NAV $22.39
Mid-Point $22.41
Premium/Discount 0.07%
Ex-Date 12/29/2015
Record Date 12/31/2015
Payable Date 1/4/2016
Amount $0.10551286
Short-Term Capital Gains N/A

The fund's investment in securities that are less actively traded or over time experience decreased trading volume may affect adversely the fund's ability to make dividend distributions.

Download Investor Materials